Literature DB >> 20361377

Clinical experience with routine use of a single combined mapping and ablation catheter for isolation of pulmonary veins in patients with paroxysmal atrial fibrillation.

Clemens Steinwender1, Simon Hönig, Franz Leisch, Robert Hofmann.   

Abstract

BACKGROUND: Catheter-based isolation of pulmonary veins has become established treatment for patients with paroxysmal atrial fibrillation. We wished to simplify the interventional procedure by using a single novel multipolar catheter for mapping and ablation in appropriate patients.
METHODS: Sixty-four patients with paroxysmal atrial fibrillation scheduled for pulmonary vein isolation were screened by cardiac computed tomography for anatomic suitability to undergo a simplified procedure with the high-density mesh ablator catheter (MESH) as the only left atrial device. The procedure was undertaken in 38 patients matching the criteria of four clearly separated pulmonary veins with ostial diameters 15-25 mm; the remaining 26 patients served as a control group and were treated using a three-dimensional mapping system guided ablation using a circular mapping catheter and a single-point ablation catheter.
RESULTS: In all 38 patients, all four pulmonary veins could be accessed and mapped with the MESH. Using the MESH, electrical isolation was achieved in 142/148 (96%) pulmonary veins with recorded potentials. In the control group, 100/105 (95%) pulmonary veins with recorded potentials could be isolated. After 6 months, clinical results did not differ significantly between the two treatment groups.
CONCLUSION: In appropriate patients, the routine single catheter approach with the MESH for mapping and ablation yields a high acute success rate despite the reduced complexity of the procedure. Long-term data on clinical success rates are needed to justify this simplified approach.

Entities:  

Mesh:

Year:  2010        PMID: 20361377     DOI: 10.1007/s00508-010-1322-4

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  32 in total

1.  A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation.

Authors:  Isabelle C Van Gelder; Vincent E Hagens; Hans A Bosker; J Herre Kingma; Otto Kamp; Tsjerk Kingma; Salah A Said; Julius I Darmanata; Alphons J M Timmermans; Jan G P Tijssen; Harry J G M Crijns
Journal:  N Engl J Med       Date:  2002-12-05       Impact factor: 91.245

2.  How to interpret and identify pulmonary vein recordings with the lasso catheter.

Authors:  Yoshihide Takahashi; Mark D O'neill; Anders Jönsson; Prashanthan Sanders; Frédéric Sacher; Mélèze Hocini; Pierre Jaïs; Jacques Clémenty; Michel Haïssaguerre
Journal:  Heart Rhythm       Date:  2006-02-28       Impact factor: 6.343

3.  Pulmonary vein encircling ablation alters the atrial electrophysiologic response to autonomic stimulation.

Authors:  Peter Salem Spector; Arshia Mehdi Noori; Nicholas Jackson Hardin; James Daniel Calame; Steve Paul Bell; Daniel Lawrence Lustgarten
Journal:  J Interv Card Electrophysiol       Date:  2007-01-17       Impact factor: 1.900

Review 4.  HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation.

Authors:  Hugh Calkins; Josep Brugada; Douglas L Packer; Riccardo Cappato; Shih-Ann Chen; Harry J G Crijns; Ralph J Damiano; D Wyn Davies; David E Haines; Michel Haissaguerre; Yoshito Iesaka; Warren Jackman; Pierre Jais; Hans Kottkamp; Karl Heinz Kuck; Bruce D Lindsay; Francis E Marchlinski; Patrick M McCarthy; J Lluis Mont; Fred Morady; Koonlawee Nademanee; Andrea Natale; Carlo Pappone; Eric Prystowsky; Antonio Raviele; Jeremy N Ruskin; Richard J Shemin
Journal:  Heart Rhythm       Date:  2007-04-30       Impact factor: 6.343

5.  Long-term efficacy of delayed cure after circumferential pulmonary vein ablation of atrial fibrillation.

Authors:  Hailong Tao; Jianzeng Dong; Xingpeng Liu; Deyong Long; Ronghui Yu; Ribo Tang; Bin Zheng; Ying Tian; Ming Zhang; Lisheng Shi; Hua He; Changsheng Ma
Journal:  J Interv Card Electrophysiol       Date:  2008-09-20       Impact factor: 1.900

6.  Atrial fibrillation is an independent determinant of increased NT-proBNP levels in outpatients with signs and symptoms of heart failure.

Authors:  Borut Jug; Miran Sebestjen; Miso Sabovic; Maja Pohar; Irena Keber
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

7.  Amiodarone versus sotalol for atrial fibrillation.

Authors:  Bramah N Singh; Steven N Singh; Domenic J Reda; X Charlene Tang; Becky Lopez; Crystal L Harris; Ross D Fletcher; Satish C Sharma; J Edwin Atwood; Alan K Jacobson; H Daniel Lewis; Dennis W Raisch; Michael D Ezekowitz
Journal:  N Engl J Med       Date:  2005-05-05       Impact factor: 91.245

8.  The prevalence of supraventricular arrhythmias with regard to the type and degree of left ventricular hypertrophy in patients with hypertensive heart disease.

Authors:  Juraj Kunisek; Luka Zaputovic; Marta Zuvic Butorac; Leon Kunisek; Ksenija Lukin-Eskinja; Rade Karlavaris; Irena Bruketa-Markic
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

9.  Anatomic approach for ganglionic plexi ablation in patients with paroxysmal atrial fibrillation.

Authors:  Demosthenes Katritsis; Eleftherios Giazitzoglou; Demetrios Sougiannis; Nicolaos Goumas; George Paxinos; A John Camm
Journal:  Am J Cardiol       Date:  2008-05-22       Impact factor: 2.778

10.  What is the real atrial fibrillation burden after catheter ablation of atrial fibrillation? A prospective rhythm analysis in pacemaker patients with continuous atrial monitoring.

Authors:  Daniel Steven; Thomas Rostock; Boris Lutomsky; Hanno Klemm; Helge Servatius; Imke Drewitz; Kai Friedrichs; Rodolfo Ventura; Thomas Meinertz; Stephan Willems
Journal:  Eur Heart J       Date:  2008-02-09       Impact factor: 29.983

View more
  1 in total

1.  Pulmonary vein isolation with Mesh Ablator versus cryoballoon catheters: 6-month outcomes.

Authors:  Robert Hofmann; Simon Hönig; Franz Leisch; Clemens Steinwender
Journal:  J Interv Card Electrophysiol       Date:  2010-10-05       Impact factor: 1.900

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.